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ABSTRACT. Low efficiency of somatic cell cloning by nuclear 
transfer has been associated with alterations of placental vascular 
architecture. Placental growth and function depend on the growth 
of blood vessels; VEGF-A and bFGF are the most important factors 
controlling neovascularization and vascular permeability in the 
placenta. We hypothesize that the VEGF-A and bFGF systems are 
disrupted in placentomes from cloned animals, contributing to the 
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placental abnormalities that are common in these clones. We determined 
mRNA expression and protein tissue localization of VEGF-A, bFGF, 
and their receptors in placentomes from cloned and non-cloned bovine 
fetuses at term. Real-time RT-PCR revealed that VEGFR-2 mRNA was 
increased in cloned male-derived placentomes, while mRNA of bFGF 
and its receptors were decreased in placentomes of cloned females. 
VEGF-A system proteins were found to be located in placentomal 
endothelial, maternal and fetal epithelial and stromal cells; there was a 
variable pattern of cellular distribution of these proteins in both cloned 
and non-cloned animals. Alterations in the expression of VEGF-A and 
bFGF systems suggest that angiogenic factors are involved in abnormal 
placental development in cloned gestations, contributing to impaired 
fetal development and poor survival rates.
Key words: Vascular endothelial growth factor; Clones; Bovines;
Fibroblast growth factor; Placenta
INTRODUCTION
Somatic cell cloning by nuclear transfer has been successfully performed in many mam-
malian species. However, cloning efficiency remains extremely low (Cezar et al., 2003; Campbell 
et al., 2005). Furthermore, live cloned offspring are not necessarily healthy (Cezar et al., 2003; 
Fulka Jr. and Fulka, 2007). The inefficiency of this technique is strongly related to placental ab-
normalities, which can cause both early and late fetal losses (Hill et al., 2000; Heyman et al., 
2002) and post-natal mortality (Cezar et al., 2003; Loi et al., 2006). Placental vascular abnormali-
ties have been described in cloned bovine (Hill et al., 2000) and ovine (De Sousa et al., 2001) 
fetuses, presumably due to abnormal aberrant gene expression (Humpherys et al., 2002; Inoue et 
al., 2002) and DNA methylation (Ohgane et al., 2001; Dindot et al., 2004).
The placenta is a key endocrine organ in pregnancy, controlling the maintenance of a suit-
able fetal environment (Malassine et al., 2003). Placental development and function are critical for 
pregnancy success and largely dependent on vessel formation in both fetal and maternal compart-
ments (Reynolds and Redmer, 1995). Vascular formation in the placenta involves the coordinated 
processes of vasculogenesis and angiogenesis requiring the interaction of inhibitory and stimula-
tory growth factors (Reynolds and Redmer, 2001). Vascular endothelial growth factor (VEGF)-A 
and basic fibroblast growth factor (bFGF) are considered to be the major factors stimulating tissue 
neovascularization in the placenta (Reynolds and Redmer, 2001; Otrock et al., 2007).
Both factors belong to one of the major families of heparin-binding angiogenic molecules. 
VEGF-A is well known as a regulator of migration and proliferation of endothelial cells and vascular 
permeability. Moreover, VEGF-A plays alternative functions in non-endothelial cells, such as the induc-
tion of monocyte migration (Clauss et al., 1996) and axonal outgrowth of neurons and glial cells (Car-
meliet and Storkebaum, 2002). The biological actions of VEGF-A are mediated by the activation of two 
specific tyrosine kinase receptors, VEGFR-1 (Flt-1/fms-like tyrosine kinase receptor 1) and VEGFR-2 
(KDR/kinase insert domain-containing region), and further modulated by the recruitment of co-recep-
tors, such as neurophilins 1 and 2, heparan sulfate, integrins, or cadherins (Cebe-Suarez et al., 2006). 
bFGF is unique among the major angiogenic growth factors in that it is pleiotropic and influences not 
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only angiogenesis but has also various other functions in development and differentiation (Gospodaro-
wicz, 1991). bFGF achieves its function by interacting with tyrosine kinase receptors (FGFR-1-4) (Klint 
and Claesson-Welsh, 1999) and heparan sulfate proteoglycans (Schlessinger et al., 1995).
The VEGF-A and bFGF systems have been identified in the placental tissue of several 
species, including the cow (Pfarrer et al., 2006a,b). In this species, VEGF-A, bFGF and its 
receptors were found throughout gestation not only in vascular endothelial cells but also in 
endometrial and trophoblast cells (Pfarrer et al., 2006a,b). The localization of VEGF-A and 
bFGF receptors in maternal and fetal epithelial cells suggests that these growth factors might 
regulate other functions than vascular development and permeability in the bovine placenta, 
including for example an autocrine action on binucleate trophoblast giant cells (TGC) migra-
tion (Pfarrer et al., 2006b). Hoffert-Goeres and collaborators (2007) demonstrated that expres-
sion of most angiogenic factors, including VEGF and VEGFR-1, are not altered as a result of 
nuclear transfer procedure in maternal and embryonic placental tissues at day 30 of gestation, 
indicating that described perturbations in angiogenesis may occur subsequently during early 
placental development and throughout gestation. Given the importance of VEGF-A and bFGF 
for placental neovascularization, their potential role in regulating other placental functions 
and the occurrence of alterations in the gene profile in cloned animals, we hypothesize that 
the VEGF-A and bFGF systems may be disrupted in placentomes from cloned bovine fetuses, 
contributing to the abnormalities of the vascular system.
MATERIAL AND METHODS
Sample collection
Bovine clones were produced by somatic cell nuclear transfer as described before 
(Yamazaki et al., 2005). Non-cloned bovines were obtained by natural mating, since the so-
matic cell nuclear transfer process, and not in vitro manipulation, is reported to induce most 
alterations in gene expression (Everts et al., 2008). Research was approved by Bioethics Com-
mittees of the Faculty of Veterinary Medicine and Animal Sciences, Faculty of Animal Sci-
ences and Food Engineering, University of São Paulo as well as the Faculty of Veterinary 
Medicine, UNESP, Jaboticabal.  
Placentomes from cloned (N = 8) and non-cloned (N = 4) bovine fetuses were col-
lected after caesarean sections at term. Characteristics of the cloned bovine fetuses are shown 
in Table 1. Placentomal tissues were either fixed for immunohistochemical analysis or imme-
diately frozen in liquid nitrogen and kept at -80°C until RNA extraction.
Clone Sex Birth weight (kg) Length of gestation (days) Outcome
C1 Female 42 294 Survived 30 days
C2 Female 37 283 Survived 15 days
C3 Female 41 290 Survived
C4 Female 40 260 Stillborn
C5 Male 35 293 Survived
C6 Male 37 290 Survived
C7 Male 57 289 Stillborn
C8 Male 14 292 Survived 7 h
Table 1. Characteristics of cloned bovines.
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Extraction of RNA and reverse transcription 
Placental tissues (one placentome per animal) were homogenized and total RNA was 
purified using Trizol® Reagent (Invitrogen Brazil Ltda.) according to manufacturer recom-
mendations. Total RNA was measured by spectrophotometry at 260 nm, and 1 µg/sample total 
DNase-treated RNA was reverse transcribed with the Superscript III kit (Invitrogen, Carlsbad, 
USA) following manufacturer instructions.
Real-time polymerase chain reaction
Real-time polymerase chain reaction (PCR) analyses were performed using an ABI 7500 
Sequence Detection System (PE Applied Biosystems, Foster City, USA). VEGF-A, VEGFR-1, 
VEGFR-2, bFGF, FGFR-1, FGFR-2, FGFR-3, and FGFR-4 primers and probes (Table 2) were de-
signed using the Assays-by-Design service from Applied Biosystems. Primers and probe for GAPDH 
(Table 2), used as endogenous control gene, were designed using the Primer Express Software (PE 
Applied Biosystems) and evaluated for their efficiency using a standard curve. In 96-well plates 31.25 
ng cDNA diluted in 5 mL nuclease-free water was added to a mixture containing 12.5 mL TaqMan 
Universal PCR Master Mix buffer (2X, Applied Biosystems); 1.0 mL forward, reverse 900 mM prim-
ers and 250 mM probe (Applied Biosystems) and 6.5 mL water to a final volume of 25 mL. All wells 
were sealed with MicroAmp Optical Adhesive Covers (Applied Biosystems), following complete 
mixture of all reagents. The following cycling parameters were employed: 2 min at 50°C, 10 min at 
95°C and 40 cycles of 15 s at 95°C (denaturation) and 1 min at 60°C (annealing and extension). PCRs 
for target genes were conducted in quadruplicates for each sample and the expression was determined 
with relative quantification by linear regression of fluorescence data. Ratios were calculated using 
the equation “relative expression = N0(target gene) / N0(GAPDH)” with N0 values calculated by the 
LinRegPCR 7.0 (Linear Regression PCR) program (Roussel et al., 2007). The log-linear part of the 
curve used for analysis contained from four to six points with the highest R2 value.
Gene (Gene Bank #)               Oligonucleotide primers                                 Probes Amplicon length (bp)
VEGF-A ►GCCCACTGAGGAGTTCAACAT
(NM_174216) ◄CTGGCTTTGGTGAGGTTTGATC FAM-CACCATGCAGATTATGMGBNFQ   60
VEGFR-1 ►GCCTGAAATCTACCAGATCATGTTG
(X94263) ◄TTCCACAAGCTCCACGAATCTT FAM-ACAAAGACCCAAAAGAAAGMGBNFQ   58
VEGFR-2 ►ACTGCAGTGATGGCGTCTT
(X94298) ◄CTTGTAGGCTCCAGTATCATTTCCA FAM-CTGTAAGATGCTCACAATTTMGBNFQ   64
bFGF ►CCGGTCAAGGAAATACTCCAGTTG
(NM_174056) ◄GGTCCTGTTTTGGGTCCAAGTTTAT FAM-TATGTGGCACTGAAACGAMGBNFQ   78
FGFR-1 ►GGATGGCACCGGAGGC
(NM_001110207) ◄CCAAGACCACACGTCACTCT FAM-CTTGTTTGACCGGATCTACMGBNFQ   62
FGFR-2 ►TCGGAATGTAACTTTTGAGGATGCT
(BC151652) ◄TCAACCATGCAGAGTGAAAGGA FAM-CTTGGCGGGTAATTCMGBNFQ   86
FGFR-3 ►GTGTCCTGCGCCTACCA
(NM_174318) ◄CCTCAGTCACCAGCACGTT FAM-CTGTGGATGCACTTCTGMGBNFQ 100
FGFR-4 ►GGAATGTATCTGCTGAGGATGCA
(AF170490) ◄AGGAAAGGCCGATGGAGTTG FAM-CCAGGCAGGTGTACTCMGBNFQ   66
GAPDH ►AAGGCCATCACCATCTTCCA
(AB098985) ◄CCAGCATCACCGCCACTT VIC-CGAGATCCTGCCAACATMGBNFQ   62
►= forward; ◄= reverse
Table 2. Oligonucleotide primers and probes for bovine VEGF-A, VEGFR-1, VEGFR-2, bFGF, FGFR-1, FGFR-
2, FGFR-3, FGFR-4, and GAPDH genes used in the real-time PCR assays.
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Immunohistochemistry
Placentomal tissues were fixed in 4% phosphate-buffered formalin solution for 24 h 
and then embedded in Paraplast® resin (Merck, Darmstadt, Germany). Sections (5 μM) were 
deparaffinized in xylene and rehydrated in a series of graded alcohols. Retrieval of antigens was 
performed by microwave treatment for 15 min in sodium citrate buffer (10 mM, pH 6.0). Slides 
were immersed in PBS (phosphate-buffered solution, pH 7.2) containing 1% hydrogen peroxide 
for 20 min to quench endogenous peroxidase activity. Blocking of non-specific binding was per-
formed using 10% horse serum in PBS for 30 min, and sections were incubated for 20 h at 4°C 
with primary antibodies (Table 3). After washes in PBS, sections were incubated with biotinyl-
ated horse anti-mouse/anti-rabbit second antibody for 1 h. Following PBS washes, a complex of 
avidin-biotin-peroxidase (ABC-Method; Vectastain-Universal-ELITE-ABC-Kit®, Vector Labo-
ratories, Burlington, Ontario, Canada) was applied for 45 min. After undergoing another rinsing 
procedure, the reaction was revealed by incubation with Vector NovaRed® for 5 min. Finally, 
sections were counterstained with hematoxylin and slides were mounted with glycerin (Merck, 
Darmstadt, Germany). Negative controls were set up with blocking peptides against VEGF-A, 
VEGFR-1 and VEGFR-2 (Blocking peptide sc-152 P, sc-316 P and sc-315 P; Santa Cruz Bio-
technology, Heidelberg, Germany) as well as substituting the primary antibody through mouse 
(bFGF, FGFR-1) or rabbit (FGFR-2 and FGFR-3) antiserum (Guerra et al., 2008).
Antibody Clone, isotype Host Peptide sequence Supplier (order number)
Anti-VEGF-A A-20, polyclonal Rabbit N-terminus of human VEGF-A Santa Cruz (sc-152)
Anti-VEGFR-1 C-17, polyclonal Rabbit C-terminus of human VEGFR-1 Santa Cruz (sc-316)
Anti-VEGFR-2 C-20, polyclonal Rabbit C-terminus of mouse VEGFR-2 Santa Cruz (sc-315)
bFGF bFM-2, IgG
1k
 monoclonal Mouse Purified bovine bFGF Upstate (05-118)
FGFR-1 19B2, IgG
1 
monoclonal Mouse Amino acids 23-325 of human FGFR-1 Upstate (05-149)
FGFR-2 polyclonal Rabbit Amino acids 809-821 of human FGFR-2 Sigma (F 0300)
FGFR-3 polyclonal Rabbit Amino acids 792-806 of human FGFR-3 Sigma (F 0425)
Table 3. Details of the primary antibodies utilized for immunohistochemistry.
Statistical analysis
Levels of mRNA are reported as means ± SEM of triplicates for each animal studied. 
Means of relative mRNA expression were analyzed using a nonparametric two-tailed t-test. 
When variances were significantly different, the nonparametric two-tailed t-test with Welch’s 
correction was applied. Means of non-cloned and cloned female and male bovine fetuses were 
analyzed by one-way ANOVA or the Tukey test. Probability level of P < 0.05 was considered 
to be significant. Statistical analyses were performed using the GraphPad Prism software (ver-
sion 4.00 for Windows, GraphPad Software, San Diego, CA, USA). 
RESULTS
Levels of mRNA for VEGF-A, bFGF and their receptors in the placentome from 
cloned and non-cloned bovine fetuses
Transcripts of VEGF system genes were detected in the placentae from all animals 
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examined at 270 days of gestation. VEGF-A mRNA levels were not statistically different (P > 
0.05) comparing placentomes from cloned and non-cloned male bovine fetuses. On the other 
hand, a tendency (P = 0.09) of higher levels of VEGF-A mRNA was noticed in cloned female 
bovine fetuses compared with non-cloned animals. VEGFR-1 mRNA content did not differ 
among placentomes from male and female fetuses compared with non-cloned animals. In con-
trast, VEGFR-2 mRNA levels were higher in cloned male bovine fetuses than in non-cloned 
animals or in cloned female bovine fetuses (P < 0.05) (Figure 1). 
Figure 1. Relative mRNA expression of VEGF-A, VEGFR-1 and VEGFR-2 in placentomes from cloned and non-
cloned bovine fetuses. A. Real-time PCR analysis demonstrated no differences (P > 0.05) in mRNA abundance of 
VEGF-A. A tendency of higher VEGF-A mRNA expression was observed in cloned female bovine fetuses (P = 0.09). 
B. No differences were observed in VEGR-1 content among animals studied. C. VEGFR-2 gene expression was 
statistically significantly higher (P < 0.05) in cloned male animals. NC = non-cloned bovine fetuses; F = cloned female 
bovine fetuses; M = cloned male bovine fetuses. NC, F and M data represent means ± SEM of 4 different animals.
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By analyzing the standard deviation of gene expression in the placentomes from 
cloned and non-cloned bovine fetuses, we observed that individual levels of VEGF-A system 
mRNA were more variable among the cloned bovine fetuses (Figure 2; P < 0.05).
Figure 2. Relative mRNA expression of VEGF-A, VEGFR-1 and VEGFR-2 in placentomes from cloned and 
non-cloned bovine fetuses. Individual analysis showed that variations in the relative mRNA transcript abundance 
of VEGF-A (A), VEGFR-1 (B) and VEGFR-2 (C) occurred more frequently and with a higher variability in 
placentomes from cloned bovine fetuses (C1-C8) than in placentomes from non-cloned (NC) animals.
bFGF and receptor transcripts were also detected in all placentae from cloned and 
non-cloned fetuses. Interestingly, placentomes of cloned female fetuses showed a decrease 
(P < 0.05) of all bFGF system genes examined either in comparison to both cloned male and 
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control fetus placentomes. Cloned male and control placentomes showed no difference in rela-
tion to bFGF and receptor expression (Figure 3). Variances of cloned and non-cloned bovine 
fetuses bFGF system mRNA levels were not statistically different (P > 0.05) (data not shown).
Figure 3. Relative mRNA expression of bFGF, FGFR-1, FGFR-2, FGFR-3, and FGFR-4 in placentomes from 
cloned and non-cloned bovine fetuses. Real-time PCR analysis demonstrated that placentomes from female cloned 
fetuses showed less bFGF system expression (P < 0.05) than non-cloned animals (A-E) and male fetuses (A, B, C, 
and E). NC = non-cloned bovine fetuses; F = cloned female bovine fetuses; M = cloned male bovine fetuses. NC, 
F and M data represent means ± SEM of 4 different animals.
Immunolocalization of VEGF-A, bFGF and their receptors in placentomes from 
cloned and non-cloned bovine fetuses
VEGF-A, bFGF and their receptor proteins were spatially localized in placentomes 
from cloned bovine fetuses by immunohistochemistry. We observed these proteins in the dif-
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ferent placental cell types and identified considerable variations in cellular distribution be-
tween placentomes from cloned and non-cloned animals. 
VEGF-A protein was localized in both maternal and fetal epithelial cells as well as stromal 
cells in placentomes from cloned and non-cloned bovine fetuses (Figure 4). Additionally, positive 
staining for VEGF-A was observed in endothelial cells from placentomal vessels. A similar VEGF-
A distribution was observed in 4 of the 6 clones studied (C2, C3, C5, and C7). In these animals, 
binucleate TGC, mononucleate trophoblast cells and maternal epithelial cells showed immunos-
taining for the protein (Figure 4b). Clone C4 showed a distinct pattern of expression, as some bi-
nucleate TGC and maternal epithelial cells presented both cytoplasmic and nuclear staining for the 
protein (Figure 4c). On the other hand, in the clone C1, VEGF-A was not expressed in binucleate 
TGC as observed in the other clones, a pattern similar to that observed in non-cloned animals (Fig-
ure 4a and d). Maternal stromal cells were positively labeled for the protein in the clones C2 and C4 
(Figure 4b and c). Compared with the VEGF-A expression in placentomal tissues from non-cloned 
bovine fetuses (Figures 4d), a stronger staining was observed in all clones studied.
Figure 4. Immunolocalization of VEGF-A in placentomes from cloned and non-cloned bovine fetuses. a, b, c: 
Clones C1, C2 and C4, respectively. d: Non-cloned animal. e: Negative control. VEGF-A is expressed in fetal 
binucleate trophoblast giant cells (arrowhead) in the clones C2 and C4 (b and c). The maternal epithelium (arrow) 
shows the signal for VEGF-A in the clone C4 (c). VEGF-A is weakly expressed in binucleate trophoblast giant cells 
(arrowhead) from clone C1 (a) and non-cloned animals (d). Open arrowhead indicates positively stained maternal 
stromal cells. MS = maternal stroma; FS = fetal stroma. Bars: 100 µM.
We further analyzed the localization of VEGF-A receptors in the placenta from cloned 
bovine fetuses. As observed for VEGF-A, receptors VEGFR-1 and VEGFR-2 were present in 
the maternal and fetal epithelium as well as in stromal and endothelial cells (Figure 5). The im-
munoreaction for VEGFR-1 was predominantly found in the maternal epithelium from clones 
C3, C4 and C5 (Figure 5b and c). This was a very similar pattern of expression of VEGFR-1 
compared to placentomes from non-cloned fetuses (Figure 5d), although less strong in non-
cloned animals. On the other hand, this pattern was not observed in the placentomes from clone 
C1 (Figure 5a). In the clones C2 and C7, specific staining for the VEGFR-1 was predominantly 
found in binucleate TGC, while the labeling was not as prominent in the other cell types.  
In analyzing VEGFR-2 spatial expression, we also observed that the localization of this 
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receptor was variable between placentae from cloned and non-cloned animals and further varied 
among the individual clones. Strikingly, clone C1 binucleate TGC showed very little or no stain-
ing for the VEGFR-2 receptor. The receptor was predominantly expressed in the fetal epithelium 
from clone C2 (Figure 5e). Clones C3, C5 and C7 showed a very similar pattern to non-cloned 
animals in VEGFR-2 expression (Figure 5g), showing both cytoplasmatic and nuclear staining 
for the receptor in the fetal and maternal cells. Another distinct pattern of VEGFR-2 expression 
was observed in the placentome from the clone C4. In this animal, nuclear staining for VEGFR-2 
was strong in fetal cell types and less intense in maternal cells (Figure 5f).
Figure 5. Immunolocalization of VEGFR-1 and VEGFR-2 in placentomes from cloned and non-cloned bovine 
fetuses. a, b, c, e, and f: Clones C1, C3, C4, C2, and C4, respectively. d and g: Non-cloned animals. h: Negative 
control. The maternal epithelium (arrow) shows staining for VEGFR-1 in the clones C3 and C4 (b and c). Although 
less strong when compared with the clones, a similar pattern of expression of VEGFR-1 is observed in the maternal 
epithelium (arrow) of a non-cloned animal (d). VEGFR-2 staining in fetal epithelium (arrow) in the clone C2 (e). 
Maternal and fetal placentome cells show signal for the receptor in the clone C4 (f). Arrowheads indicate VEGFR-1 
(a, b and c) and VEGFR-2 (e, f and g) positively stained binucleate trophoblast giant cells. Open arrowheads 
indicate VEGFR-1 (b and c) and VEGFR-2 (f and g) positively stained fetal mononucleate trophoblast cells. MS = 
maternal stroma; FS = fetal stroma. Bars: 100 µM.
With respect to bFGF and its receptor proteins, a less variable pattern of expression was 
observed among the animals analyzed. All proteins studied were less expressed in placentomes 
of cloned female bovine fetuses. In addition, cellular distribution of these proteins showed a 
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distinct pattern among clones and between cloned and non-cloned bovine placentomes (Figure 
6). bFGF protein was localized in maternal and fetal epithelial and stromal cells in placentomes 
from non-cloned bovine fetuses (Figure 6a). On the other hand, a positive signal for bFGF was 
only observed in the maternal stromal cells in the placentomes from the cloned fetuses (Figure 
6b). The protein was expressed in endothelial cells in cloned and non-cloned animals.
Analyzing the localization of bFGF receptors in the placenta from cloned bovine 
fetuses, we observed that all three receptors were localized in the maternal and fetal epithe-
lium as well as in stromal and endothelial cells (Figure 6). We observed that all placental 
cell types, excluding fetal stromal cells expressed the FGFR-1 in the cloned and non-cloned 
fetuses (Figure 6c and d). FGFR-2 and FGFR-3 were localized in all placental cell types as 
well (Figure 6e-h); however, FGFR-3 localization was predominantly nuclear in these cells 
(Figure 6g and h) in cloned and non-cloned fetuses.
Figure 6. Immunolocalization of bFGF, FGFR-1, FGFR-2, and FGFR-3 in placentomes from cloned and non-
cloned bovine fetuses. a, c, e, and g: Non-cloned animals. b, d, f, and h: Cloned animals. i: Negative control. 
All maternal and fetal placental cells showed staining for bFGF in non-cloned fetuses, including the binucleate 
trophoblast giant cells (TGC) (arrowhead) and maternal stromal cells (open arrowhead) (a). On the other hand, only 
maternal stromal cells expressed the protein in cloned animals (b). Although less strong when compared with the 
non-cloned animals, a similar pattern of expression of FGFR-1 was observed in maternal epithelial cells (arrow) and 
binucleate TGC (arrowhead) in non-cloned (c) and cloned animals (d). FGFR-2 is weakly expressed in binucleate 
TGC (arrowhead) from clones (f) compared with non-cloned animals (e). FGFR-3 staining was predominantly 
nuclear in binucleate TGC (arrowhead) and maternal epithelial cells (open arrow) from non-cloned (g) and cloned 
fetuses (h). MS = maternal stroma; FS = fetal stroma. Bars: 100 µM.
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DISCUSSION
Extensive placental angiogenesis is essential for a successful maintenance of ges-
tation (Reynolds and Redmer, 1995, 2001). VEGF-A and bFGF have been demonstrated 
to be the two major angiogenic factors inducing placental vessel development (Reynolds 
and Redmer, 1995, 2001). Several reports have described morphological analysis of the 
placenta from cloned bovines and there is a consensus that numerous alterations are a 
common feature in these placentae, including placental overgrowth and vascular disorders 
(Hill et al., 2000; Heyman et al., 2002; Constant et al., 2006; Miglino et al., 2007).
Altered vascular development of placenta from clones could be due to modifications 
in the expression of placental factors (Constant et al., 2006). Placental gene expression is in-
fluenced by cytosine methylation pattern of the DNA, and improper reprogramming of DNA 
methylation in the chorion of clones leads to radically altered gene expression profiles in the 
placenta (Dindot et al., 2004). Based on that, we proposed to investigate VEGF-A and bFGF 
system expression in placentas from cloned bovines. Placentomes here studied were previously 
submitted to morphological analysis (Miglino et al., 2007), and all samples displayed altera-
tions, including deranged vascular structure in the cotyledons. Herein, we clearly demonstrate 
that both systems have altered expression in the placentomes at term, which could be related to 
abnormalities in the placental development as well as fetal viability. In fact, although nuclear 
transfer-derived placentae supported gestation until term, we observed low survival rates of the 
offspring (36.75%). Survival of fetuses was not related to degree of perturbation in gene and 
protein expression, suggesting that individual compensatory mechanisms could be triggered 
during gestation in order to overcome disrupted expression of important genes in the placenta 
(Constant et al., 2006) allowing gestation to come to term, however, down- or up-regulation 
of important vasculogenic growth factors and respective receptors might have an impact on 
placental function and, consequently, on fetal development and survival. Previous investigation 
demonstrated that expression of most angiogenic factors, including VEGF and VEGFR-1, is 
not altered as a result of nuclear transfer procedure in placental tissues at day 30 of gestation 
(Hoffert-Goeres et al., 2007). These data, associated with our results, suggest that perturbations 
in vascular development may occur throughout gestation.
In this study, we identified a decrease in bFGF and a tendency for higher VEGF-A 
expression in female but not in male nuclear transfer-derived term placentomes. In fact, the 
modulatory role of bFGF in the VEGF and VEGFR expression has already been described 
in the corpus luteum (Stavri et al., 1995; Gabler et al., 2004; Yamashita et al., 2008) and de-
termines the ideal balance of angiogenic factors and corpus luteum vascularization progress. 
As observed in the corpus luteum, this mechanism may be active also in the placenta and the 
decrease of bFGF and FGFR expression may determine an increase of VEGF-A mRNA ex-
pression in the placentomes. Interestingly, disruption of bFGF system occurred only in female 
placentomes, which could be related to deficient X-chromosome inactivation, which in turn 
depends also on methylation of cytosine residues (Cezar et al., 2003). Different methylation 
patterns of chorion-specific genes have been described in male and female nuclear transfer-
derived bovine embryos (Dindot et al., 2004), contributing to the understanding that some 
genes may be altered in the placenta of one gender and not the other. In addition, it is possible 
that bFGF functions not related to angiogenesis may be altered in the placenta of cloned fe-
tuses, contributing to the decreased survival rate of females (25%) compared to males (50%). 
Male-cloned fetuses seem to compensate vascular maintenance demands, at least in terms of 
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VEGFR-2 up-regulation, which could also influence bFGF system expression (Gabler et al., 
2004) and regulate its transcription to normal levels. 
During early gestation, a physiological condition of hypoxia is observed in the uterine 
environment (James et al., 2006) and hypoxia-induced factors, such as VEGF-A, bFGF and their 
receptors, have particular importance in the vasculogenesis and angiogenesis required to establish 
an adequate vascular network and support both placental and fetal development (Wheeler et al., 
1995). Herein we demonstrated that VEGF-A and bFGF systems are expressed at late gestation 
in placental vessels, reinforcing their importance in the maintenance of vasculature and control 
of vascular permeability throughout pregnancy (Cheung, 1997). Furthermore, the localization of 
VEGF and bFGF receptors in maternal and fetal epithelial and stromal cells suggests that both 
growth factors might have other biological actions in the bovine placental tissue. In fact, the spatial-
temporal distribution of VEGF-A and bFGF systems during gestation indicates that these growth 
factors play different roles in the placenta (Winther et al., 1999; Pfarrer et al., 2006a,b). We identi-
fied differences in cellular distribution of target proteins comparing cloned and non-cloned placen-
tal tissues as well as among clones. These data indicate that function of VEGF and bFGF as a local 
paracrine/autocrine factor (Pfarrer et al., 2006a,b) could be compromised, due to the absence of 
these growth factors or their receptors in specific placental cell types. This lack may lead to altered 
placental function and contribute to decreased survival of cloned bovine fetuses.
Besides individual differences in protein cellular localization, we observed individual 
variations in the levels of gene expression in the placenta of our cloned animals, especially con-
sidering VEGF-A system. The same observation has been described in the literature. A study 
with Sertoli cell- and cumulus cell-derived clones demonstrated that clones differed from each 
other and from normal individuals produced by sexual reproduction and only a few genes were 
universally affected in all clones (Kohda et al., 2005). Variations in the expression of crucial 
genes related to placental development were observed among bovine blastocysts submitted to 
the same nuclear transfer process (Hall et al., 2005). In term placentae from mice, important al-
terations of imprinted genes were observed among clones derived from stem cell nuclear transfer 
(Humpherys et al., 2002). Moreover, another study with term murine placenta demonstrated 
different mean expression rates among cloned and non-cloned animals for several imprinted and 
non-imprinted genes, including VEGFR-2 (Inoue et al., 2002). All clones from this study were 
derived from adult fibroblast nuclear transfer and differences were observed between means of 
VEGFR-2 and bFGF system gene expression in the placental tissue from cloned and non-cloned 
bovine fetuses. In addition, individual variations were more evident among clones. Combined, 
these data indicate the importance of individual analyses of cloned animals, since the variation in 
mean expression levels could mask gene expression abnormalities present in individual clones. 
In summary, we reported that the VEGF-A and bFGF systems have altered expression 
in nuclear transfer-derived placentae at term gestation. The fact that cloned gestations came to 
term even though the expression of important angiogenic factors was disturbed in the placenta, 
emphasizes the concept that the most remarkable changes in the expression of angiogenic fac-
tors from compromised pregnancies must be found during the course of gestation (Cezar et al., 
2003; Dindot et al., 2004). We show modified late-gestation expression of VEGF-A and bFGF 
for the first time. These alterations and possibly modifications in other genes, as suggested by 
Everts and collaborators (2008), can effectively contribute to the described phenotypic (Mi-
glino et al., 2007) disturbances found in these animals and consequently to the poor fetal devel-
opment and low survival rates of the clones.
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